form8k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report: February 1, 2010
(Date
of earliest event reported)
MedCom
USA, Incorporated
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-25474
|
65-0287558
|
|
(State
or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification Number)
|
7038
E. 5th
Avenue
Scottsdale,
AZ 85251
(Address
of principal executive offices, including zip code)
(480)-970-1540
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
£ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
£ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item
5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
On
February 1, 2010, MedCom USA, Inc. ("MedCom" or the "Company") terminated
Michael De La Garza as the Company's Chief Operating Officer. His
termination was effective immediately.
Certain
statements in this Form 8-K that are not historical facts are “forward-looking
statements” within the meaning of the Private Securities Litigation Reform Act
of 1995. Such statements may be identified by the use of words such
as “anticipate,” “believe,” “expect,” “future,” “may,” “will,” “would,”
“should,” “plan,” “projected,” “intend,” and similar
expressions. Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause the actual
results, performance or achievements of MedCom to be materially different from
those expressed or implied by such forward-looking
statements. MedCom’s future operating results are dependent upon many
factors, including, but not limited to, MedCom’s ability to: (i) build the
management and human resources and infrastructure necessary to support the
growth of its business; (ii) obtain sufficient capital to pay existing debts;
(iii) competitive factors and developments beyond MedCom’s control; and (iv)
other risk factors discussed in MedCom’s periodic filings with the Securities
and Exchange commission, including MedCom’s Form 10-K filed on September 29,
2008. MedCom undertakes no obligation to update any forward-looking statements
made in this Form 8-K to reflect future events or developments.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
MedCom
USA, Incorporated
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Robert H.
Kite
|
|
|
|
Robert
H. Kite
|
|
|
|
Chairman
of the Board
|
Date: February
1, 2010